Review



anti pdgfr β  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc anti pdgfr β
    Anti Pdgfr β, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 602 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pdgfr+beta/PDGF+Receptor+beta+Rabbit+mAb/pm41916297-748-60-62
    Average 96 stars, based on 602 article reviews
    anti pdgfr β - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Quantitative Proteomics and Phosphoproteomics Analysis of Patient-Derived Ovarian Cancer Stem Cells
    Article Snippet: .. The membranes were incubated overnight at 4 °C with the following primary antibodies: GPNMB (LSBio, cat# LS- B11132 ), CHI3L1 (R&D Systems, cat# AF2599), phospho-PDGFR beta tyrosine-1009 (Cell Signaling Technology, cat# 3124), PDGFR beta (Cell Signaling Technology cat# #4564), GAPDH (Sigma-Aldrich, cat# ABS16), and vinculin (Sigma-Aldrich, cat# V9131). .. Membranes were incubated with HRP-conjugated secondary antibody (Bio-Rad Laboratories) for 1 h at room temperature.

    Article Title: Biological relevance of tissue factor and IL-6 in arteriovenous malformations.
    Article Snippet: Arteriovenous malformations (AVMs) are congenital abnormal vessels that shunt blood directly from the arterial to the venous system without a capillary bed.. The underlying pathology of AVMs is not fully understood.. The objective of the study was to determine the association between the expression patterns of tissue factor (TF) and interleukin-6 (IL-6) in AVMs with clinical and pathological findings.

    Article Title: CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer
    Article Snippet: .. Western blot: 1:1000 CD26 (Abcam, clone EPR18215, ab187048) whole mount analysis: 1:200. western blot analysis: 1:1000 rat-anti-Keratin 8 (DSHB, clone TROMA-1) dilution: 1:200 rabbit-anti-Keratin 14 (Abcam, clone EPR17350, ab181595 ) dilution 1:1000 rabbit-anti-FSP1 (Abcam, EPR14639(2), ab197896) dilution 1:2000 PDGFR-beta (Cell signaling, 28E1, #3169) dilution 1:50 Alpha-smooth muscle actin (Fisher scientific, polyclonal, RB-9010) dilution 1:200 vimentin (Cell signaling, D21H3, #5741) dilution 1:200 EpCAM (Abcam, E144, ab32392) dilution 1:200 E-cadherin (Cell signaling, 24E10, #3195) dilution 1:200 anti-CXCL12 (R&D systems, 79014, MAB310) neutralizing ab concentration: 100 ug/ml anti-CXCL2 (Thermo Fisher, 40605, MA5-23737) neutralizing ab concentration: 50 ug/ml rabbit anti-C3 (Abcam, clone EPR19394, ab200999) dilution 1:1000 rabbit anti-TNC (Abcam, clone EPR4219, ab108930) dilution 1:1000 rabbit anti-TGFb1 (Abcam, clone EPR18163, ab179695) dilution 1:1000 mouse anti-Actin (Sigma-Aldrich, clone AC-15, A5441) dilution 1:2000 EnVision+ HRP-conjugated anti-rabbit (ready to use) (Dako Agilent, polyclonal, K400311-2) undiluted (RTU) rabbit-anti-mouse HRP (Dako, polyclonal, P0260) dilution 1:2000 goat-anti-rabbit HRP (Dako, polyclonal, P0448) dilution 1:2000 goat-anti-mouse IgG conjugated to Alexa Fluor 488 (ThermoFisher, polyclonal, A-11001) dilution 1:1000 goat-anti-rabbit IgG conjugated to Alexa Fluor 568 (ThermoFisher, polyclonal, A-11011) dilution: 1:1000 goat-anti-rat IgG conjugated to Alexa Fluor 647 (ThermoFisher, polyclonal, A-21247) dilution 1:1000 goat anti-rabbit IgG conjugated to Alexa-647 (Thermo Fisher, polyclonal, A21245) dilution: 1:400 goat anti-mouse IgGconjugated to Alexa-647 (Thermo Fisher, polyclonal, A21241) dilution 1:400 donkey anti-rabbit conjugated to Alexa-568 (Thermo Fisher, polyclonal, A10042) dilution: 1:400 Details regarding the application and incubation can be found in the material and methods section. ..

    Article Title: Quantitative proteomics and phosphoproteomics analysis of patient-derived ovarian cancer stem cells.
    Article Snippet: .. The membranes were incubated overnight at 4°C with the following primary antibodies: GPNMB (LSBio, cat# LS-B11132), CHI3L1 (R&D Systems, cat# AF2599), phospho-PDGFR beta tyrosine-1009 (Cell Signaling Technology, cat# 3124), PDGFR beta (Cell Signaling Technology cat# #4564), GAPDH (Sigma-Aldrich, cat# ABS16), vinculin Jo urn al Pr e-p roo f 4 (Sigma-Aldrich, cat# V9131). .. Membranes were incubated with HRP-conjugated secondary antibody (Bio-Rad Laboratories) for 1 hour at room temperature.

    Blocking Assay:

    Article Title: Biological relevance of tissue factor and IL-6 in arteriovenous malformations.
    Article Snippet: Arteriovenous malformations (AVMs) are congenital abnormal vessels that shunt blood directly from the arterial to the venous system without a capillary bed.. The underlying pathology of AVMs is not fully understood.. The objective of the study was to determine the association between the expression patterns of tissue factor (TF) and interleukin-6 (IL-6) in AVMs with clinical and pathological findings.

    Marker:

    Article Title: Biological relevance of tissue factor and IL-6 in arteriovenous malformations.
    Article Snippet: Arteriovenous malformations (AVMs) are congenital abnormal vessels that shunt blood directly from the arterial to the venous system without a capillary bed.. The underlying pathology of AVMs is not fully understood.. The objective of the study was to determine the association between the expression patterns of tissue factor (TF) and interleukin-6 (IL-6) in AVMs with clinical and pathological findings.

    Western Blot:

    Article Title: CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer
    Article Snippet: .. Western blot: 1:1000 CD26 (Abcam, clone EPR18215, ab187048) whole mount analysis: 1:200. western blot analysis: 1:1000 rat-anti-Keratin 8 (DSHB, clone TROMA-1) dilution: 1:200 rabbit-anti-Keratin 14 (Abcam, clone EPR17350, ab181595 ) dilution 1:1000 rabbit-anti-FSP1 (Abcam, EPR14639(2), ab197896) dilution 1:2000 PDGFR-beta (Cell signaling, 28E1, #3169) dilution 1:50 Alpha-smooth muscle actin (Fisher scientific, polyclonal, RB-9010) dilution 1:200 vimentin (Cell signaling, D21H3, #5741) dilution 1:200 EpCAM (Abcam, E144, ab32392) dilution 1:200 E-cadherin (Cell signaling, 24E10, #3195) dilution 1:200 anti-CXCL12 (R&D systems, 79014, MAB310) neutralizing ab concentration: 100 ug/ml anti-CXCL2 (Thermo Fisher, 40605, MA5-23737) neutralizing ab concentration: 50 ug/ml rabbit anti-C3 (Abcam, clone EPR19394, ab200999) dilution 1:1000 rabbit anti-TNC (Abcam, clone EPR4219, ab108930) dilution 1:1000 rabbit anti-TGFb1 (Abcam, clone EPR18163, ab179695) dilution 1:1000 mouse anti-Actin (Sigma-Aldrich, clone AC-15, A5441) dilution 1:2000 EnVision+ HRP-conjugated anti-rabbit (ready to use) (Dako Agilent, polyclonal, K400311-2) undiluted (RTU) rabbit-anti-mouse HRP (Dako, polyclonal, P0260) dilution 1:2000 goat-anti-rabbit HRP (Dako, polyclonal, P0448) dilution 1:2000 goat-anti-mouse IgG conjugated to Alexa Fluor 488 (ThermoFisher, polyclonal, A-11001) dilution 1:1000 goat-anti-rabbit IgG conjugated to Alexa Fluor 568 (ThermoFisher, polyclonal, A-11011) dilution: 1:1000 goat-anti-rat IgG conjugated to Alexa Fluor 647 (ThermoFisher, polyclonal, A-21247) dilution 1:1000 goat anti-rabbit IgG conjugated to Alexa-647 (Thermo Fisher, polyclonal, A21245) dilution: 1:400 goat anti-mouse IgGconjugated to Alexa-647 (Thermo Fisher, polyclonal, A21241) dilution 1:400 donkey anti-rabbit conjugated to Alexa-568 (Thermo Fisher, polyclonal, A10042) dilution: 1:400 Details regarding the application and incubation can be found in the material and methods section. ..

    Concentration Assay:

    Article Title: CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer
    Article Snippet: .. Western blot: 1:1000 CD26 (Abcam, clone EPR18215, ab187048) whole mount analysis: 1:200. western blot analysis: 1:1000 rat-anti-Keratin 8 (DSHB, clone TROMA-1) dilution: 1:200 rabbit-anti-Keratin 14 (Abcam, clone EPR17350, ab181595 ) dilution 1:1000 rabbit-anti-FSP1 (Abcam, EPR14639(2), ab197896) dilution 1:2000 PDGFR-beta (Cell signaling, 28E1, #3169) dilution 1:50 Alpha-smooth muscle actin (Fisher scientific, polyclonal, RB-9010) dilution 1:200 vimentin (Cell signaling, D21H3, #5741) dilution 1:200 EpCAM (Abcam, E144, ab32392) dilution 1:200 E-cadherin (Cell signaling, 24E10, #3195) dilution 1:200 anti-CXCL12 (R&D systems, 79014, MAB310) neutralizing ab concentration: 100 ug/ml anti-CXCL2 (Thermo Fisher, 40605, MA5-23737) neutralizing ab concentration: 50 ug/ml rabbit anti-C3 (Abcam, clone EPR19394, ab200999) dilution 1:1000 rabbit anti-TNC (Abcam, clone EPR4219, ab108930) dilution 1:1000 rabbit anti-TGFb1 (Abcam, clone EPR18163, ab179695) dilution 1:1000 mouse anti-Actin (Sigma-Aldrich, clone AC-15, A5441) dilution 1:2000 EnVision+ HRP-conjugated anti-rabbit (ready to use) (Dako Agilent, polyclonal, K400311-2) undiluted (RTU) rabbit-anti-mouse HRP (Dako, polyclonal, P0260) dilution 1:2000 goat-anti-rabbit HRP (Dako, polyclonal, P0448) dilution 1:2000 goat-anti-mouse IgG conjugated to Alexa Fluor 488 (ThermoFisher, polyclonal, A-11001) dilution 1:1000 goat-anti-rabbit IgG conjugated to Alexa Fluor 568 (ThermoFisher, polyclonal, A-11011) dilution: 1:1000 goat-anti-rat IgG conjugated to Alexa Fluor 647 (ThermoFisher, polyclonal, A-21247) dilution 1:1000 goat anti-rabbit IgG conjugated to Alexa-647 (Thermo Fisher, polyclonal, A21245) dilution: 1:400 goat anti-mouse IgGconjugated to Alexa-647 (Thermo Fisher, polyclonal, A21241) dilution 1:400 donkey anti-rabbit conjugated to Alexa-568 (Thermo Fisher, polyclonal, A10042) dilution: 1:400 Details regarding the application and incubation can be found in the material and methods section. ..

    Synthesized:

    Article Title: ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2
    Article Snippet: .. The primary antibodies used in this study include the ones against ROBO2 (R&D System, Abnova, Santa Cruz Biotechnology), nephrin (custom synthesized) (Topham et al., 1999), Nck (Upstate/Millipore), podocin (Sigma), nidogen (Santa Cruz Biotechnology), Pecam1 (BD Biosciences), WT1 (Santa Cruz Biotechnology), SLIT2 (Santa Cruz Biotechnology), PDGFR beta (Cell Signaling), Synaptopodin (Santa Cruz Biotechnology). .. Images were obtained using a Perkin Elmer UltraView LCI multi-point spinning disc laser-scanning confocal microscope and a Zeiss LSM 510 confocal laser scanning microscope with a 60× oil immersion objective.

    other:

    Article Title: Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis
    Article Snippet: PDGFR-beta , , Cell Signaling Technology , 3169 , 1:1000.

    Immunohistochemistry:

    Article Title: Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2
    Article Snippet: .. The primary antibodies used in this study include the ones against ROBO2 (R&D System, Abnova, Santa Cruz Biotechnology), nephrin (custom synthesized) (Topham et al., 1999), Nck (Upstate/Millipore), podocin (Sigma), nidogen (Santa Cruz Biotechnology), Pecam1 (BD Biosciences), WT1 (Santa Cruz Biotechnology), SLIT2 (Santa Cruz Biotechnology), PDGFR beta (Cell Signaling), Synaptopodin (Santa Cruz Biotechnology). .. Images were obtained using a Perkin Elmer UltraView LCI multi-point spinning disc laser-scanning confocal microscope and a Zeiss LSM 510 confocal laser scanning microscope with a 60× oil immersion objective.



    Similar Products

    86
    Huabio Inc anti pdgfr beta
    Anti Pdgfr Beta, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pdgfr+beta/anti+pdgfb/pmc13152276-8-2-7
    Average 86 stars, based on 1 article reviews
    anti pdgfr beta - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    96
    R&D Systems goat anti pdgfr β
    Goat Anti Pdgfr β, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pdgfr+beta/Mouse+PDGF+R+beta+Antibody/pmc13124745-67-41-45
    Average 96 stars, based on 1 article reviews
    goat anti pdgfr β - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc anti pdgfr β
    Anti Pdgfr β, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pdgfr+beta/PDGF+Receptor+beta+Rabbit+mAb/pm41916297-748-60-62
    Average 96 stars, based on 1 article reviews
    anti pdgfr β - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc pdgfr
    (A-B) Masson’s trichrome (left) and PDGFRβ (right) staining of primary tumors from MDA-MB-134 (A) and SUM44PE (B) orthotopic xenografts and spontaneous metastases to the indicated organs. (C) Masson’s trichrome staining of primary tumors from MDA-MB-330 orthotopic xenografts and spontaneous metastases to the indicated organs. <t>(D)</t> <t>Ly6G</t> staining of primary tumors from MDA-MB-134, SUM44PE, MDA-MB-330 and BCK4 orthotopic xenografts. Insets show a small portion of the images at higher magnification. Scale bar: 40 μm.
    Pdgfr, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pdgfr+beta/PDGF+Receptor+beta+Rabbit+mAb/bio_rxiv__64898__2026__03__17__712396-69-28-29
    Average 96 stars, based on 1 article reviews
    pdgfr - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    94
    Novus Biologicals pdgfr β
    (A-B) Masson’s trichrome (left) and PDGFRβ (right) staining of primary tumors from MDA-MB-134 (A) and SUM44PE (B) orthotopic xenografts and spontaneous metastases to the indicated organs. (C) Masson’s trichrome staining of primary tumors from MDA-MB-330 orthotopic xenografts and spontaneous metastases to the indicated organs. <t>(D)</t> <t>Ly6G</t> staining of primary tumors from MDA-MB-134, SUM44PE, MDA-MB-330 and BCK4 orthotopic xenografts. Insets show a small portion of the images at higher magnification. Scale bar: 40 μm.
    Pdgfr β, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pdgfr+beta/PDGF+R+beta+Antibody+(APB5)+-+BSA+Free/pm41739927-419-92-94
    Average 94 stars, based on 1 article reviews
    pdgfr β - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    96
    R&D Systems goat pdgfr β
    Conditional knockout of Tgfβ1 in macrophage lineage cells reduces pSmad2 levels and promotes functional recovery in SCI mice. a – d ELISA analysis showing the concentration of TGF-β in the spinal cord and the serum after SCI in each mouse for the groups indicated (* P < 0.05, ** P < 0.01, n = 4). e Representative Western blots showing the activation of phosphorylated Smad (pSmad) signaling. f Representative images of immunofluorescent staining of pSmad2 + (red), platelet-derived growth factor receptor-β + <t>(PDGFR-β</t> + ) (green) pericytes , and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. g Representative immunofluorescence images of PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 2 weeks after SCI. Scale bars, 200 µm. h Quantitative analysis of the number of pSmad2 + cells (**** P < 0.000 1, n = 6). i Quantitative analysis of the number of PDGFR-β + cells (** P < 0.01, n = 6). j , k Illustrations of the hot plate test and the von Frey test. l Quantitative analysis of hindpaw withdrawal time responding to temperature (hot plate test, ** P < 0.01, n = 8). m , n Quantitative analysis of hindpaw withdrawal frequency responding to mechanical stimulation (von Frey test, 0.7 mN and 3.9 mN, * P < 0.05, ** P < 0.01, n = 8). o Quantitative analysis of Basso Mouse Scale (BMS) score between Tgfb1 flox / flox control mice after SCI, Tgfb1 LysM-cre −/− mice after SCI, and Tgfb1 flox/flox control mice without SCI (* P < 0.05, n = 8). PWF paw withdrawal frequency. LF left forepaw, RF right forepaw, RH right hindpaw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file
    Goat Pdgfr β, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pdgfr+beta/Mouse+PDGF+R+beta+Antibody/pmc12936232-280-78-82
    Average 96 stars, based on 1 article reviews
    goat pdgfr β - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc pdgfr 13
    Conditional knockout of Tgfβ1 in macrophage lineage cells reduces pSmad2 levels and promotes functional recovery in SCI mice. a – d ELISA analysis showing the concentration of TGF-β in the spinal cord and the serum after SCI in each mouse for the groups indicated (* P < 0.05, ** P < 0.01, n = 4). e Representative Western blots showing the activation of phosphorylated Smad (pSmad) signaling. f Representative images of immunofluorescent staining of pSmad2 + (red), platelet-derived growth factor receptor-β + <t>(PDGFR-β</t> + ) (green) pericytes , and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. g Representative immunofluorescence images of PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 2 weeks after SCI. Scale bars, 200 µm. h Quantitative analysis of the number of pSmad2 + cells (**** P < 0.000 1, n = 6). i Quantitative analysis of the number of PDGFR-β + cells (** P < 0.01, n = 6). j , k Illustrations of the hot plate test and the von Frey test. l Quantitative analysis of hindpaw withdrawal time responding to temperature (hot plate test, ** P < 0.01, n = 8). m , n Quantitative analysis of hindpaw withdrawal frequency responding to mechanical stimulation (von Frey test, 0.7 mN and 3.9 mN, * P < 0.05, ** P < 0.01, n = 8). o Quantitative analysis of Basso Mouse Scale (BMS) score between Tgfb1 flox / flox control mice after SCI, Tgfb1 LysM-cre −/− mice after SCI, and Tgfb1 flox/flox control mice without SCI (* P < 0.05, n = 8). PWF paw withdrawal frequency. LF left forepaw, RF right forepaw, RH right hindpaw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file
    Pdgfr 13, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pdgfr+beta/PDGF+Receptor+beta+Rabbit+mAb/us12559560-644-123-125
    Average 96 stars, based on 1 article reviews
    pdgfr 13 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    (A-B) Masson’s trichrome (left) and PDGFRβ (right) staining of primary tumors from MDA-MB-134 (A) and SUM44PE (B) orthotopic xenografts and spontaneous metastases to the indicated organs. (C) Masson’s trichrome staining of primary tumors from MDA-MB-330 orthotopic xenografts and spontaneous metastases to the indicated organs. (D) Ly6G staining of primary tumors from MDA-MB-134, SUM44PE, MDA-MB-330 and BCK4 orthotopic xenografts. Insets show a small portion of the images at higher magnification. Scale bar: 40 μm.

    Journal: bioRxiv

    Article Title: Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma

    doi: 10.64898/2026.03.17.712396

    Figure Lengend Snippet: (A-B) Masson’s trichrome (left) and PDGFRβ (right) staining of primary tumors from MDA-MB-134 (A) and SUM44PE (B) orthotopic xenografts and spontaneous metastases to the indicated organs. (C) Masson’s trichrome staining of primary tumors from MDA-MB-330 orthotopic xenografts and spontaneous metastases to the indicated organs. (D) Ly6G staining of primary tumors from MDA-MB-134, SUM44PE, MDA-MB-330 and BCK4 orthotopic xenografts. Insets show a small portion of the images at higher magnification. Scale bar: 40 μm.

    Article Snippet: Primary antibodies were as follows: ERα (clone SP1 from Roche, #05278414001), CDH1 (Clone 36 from Roche, #05905290001), p120 (clone 98/pp120, BD Biosciences, BD610134), PR (clone 1E2, Roche, 05278392001), PDGFR (Cell Signaling Technologies, CST #3169, 1:100), and Ly6G (BD, #551459, 1:100).

    Techniques: Staining

    Conditional knockout of Tgfβ1 in macrophage lineage cells reduces pSmad2 levels and promotes functional recovery in SCI mice. a – d ELISA analysis showing the concentration of TGF-β in the spinal cord and the serum after SCI in each mouse for the groups indicated (* P < 0.05, ** P < 0.01, n = 4). e Representative Western blots showing the activation of phosphorylated Smad (pSmad) signaling. f Representative images of immunofluorescent staining of pSmad2 + (red), platelet-derived growth factor receptor-β + (PDGFR-β + ) (green) pericytes , and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. g Representative immunofluorescence images of PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 2 weeks after SCI. Scale bars, 200 µm. h Quantitative analysis of the number of pSmad2 + cells (**** P < 0.000 1, n = 6). i Quantitative analysis of the number of PDGFR-β + cells (** P < 0.01, n = 6). j , k Illustrations of the hot plate test and the von Frey test. l Quantitative analysis of hindpaw withdrawal time responding to temperature (hot plate test, ** P < 0.01, n = 8). m , n Quantitative analysis of hindpaw withdrawal frequency responding to mechanical stimulation (von Frey test, 0.7 mN and 3.9 mN, * P < 0.05, ** P < 0.01, n = 8). o Quantitative analysis of Basso Mouse Scale (BMS) score between Tgfb1 flox / flox control mice after SCI, Tgfb1 LysM-cre −/− mice after SCI, and Tgfb1 flox/flox control mice without SCI (* P < 0.05, n = 8). PWF paw withdrawal frequency. LF left forepaw, RF right forepaw, RH right hindpaw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Journal: Bone Research

    Article Title: TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury

    doi: 10.1038/s41413-026-00507-7

    Figure Lengend Snippet: Conditional knockout of Tgfβ1 in macrophage lineage cells reduces pSmad2 levels and promotes functional recovery in SCI mice. a – d ELISA analysis showing the concentration of TGF-β in the spinal cord and the serum after SCI in each mouse for the groups indicated (* P < 0.05, ** P < 0.01, n = 4). e Representative Western blots showing the activation of phosphorylated Smad (pSmad) signaling. f Representative images of immunofluorescent staining of pSmad2 + (red), platelet-derived growth factor receptor-β + (PDGFR-β + ) (green) pericytes , and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. g Representative immunofluorescence images of PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 2 weeks after SCI. Scale bars, 200 µm. h Quantitative analysis of the number of pSmad2 + cells (**** P < 0.000 1, n = 6). i Quantitative analysis of the number of PDGFR-β + cells (** P < 0.01, n = 6). j , k Illustrations of the hot plate test and the von Frey test. l Quantitative analysis of hindpaw withdrawal time responding to temperature (hot plate test, ** P < 0.01, n = 8). m , n Quantitative analysis of hindpaw withdrawal frequency responding to mechanical stimulation (von Frey test, 0.7 mN and 3.9 mN, * P < 0.05, ** P < 0.01, n = 8). o Quantitative analysis of Basso Mouse Scale (BMS) score between Tgfb1 flox / flox control mice after SCI, Tgfb1 LysM-cre −/− mice after SCI, and Tgfb1 flox/flox control mice without SCI (* P < 0.05, n = 8). PWF paw withdrawal frequency. LF left forepaw, RF right forepaw, RH right hindpaw. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Article Snippet: The sections were incubated with primary antibodies to rabbit 5-HT (1:50, sc-65495, Santa Cruz Biotechnology, Dallas, TX, USA), mouse β-III-tubulin (1:100, MA1-118, Invitrogen, Carlsbad, CA, USA), rabbit PGP9.5 (1:250, ab108986, Abcam, Cambridge, UK), mouse PGP9.5 (1:50, ab8189, Abcam), rabbit Fibronectin (1:100, ab2413, Abcam), mouse Fibronectin (1:100, ab6328, Abcam), rabbit Collagen III (1:100, ab7778, Abcam), chicken GFAP (1:500, ab4674, Abcam), mouse Collagen1α1 (1:50, sc-293182, Santa Cruz Biotechnology), rabbit Phospho SAMD2 (1:100, 44-244 G, Invitrogen), rabbit PDGFR-β (1:100, ab32570, Abcam), goat PDGFR-β (1:100, AF1042, R&D Systems), rabbit FSP1 (1:300, 07-2274, MilliporeSigma, Burlington, MA, USA), and chicken green fluorescent protein (1:250, ab13970, Abcam) overnight at 4 °C.

    Techniques: Knock-Out, Functional Assay, Enzyme-linked Immunosorbent Assay, Concentration Assay, Western Blot, Activation Assay, Staining, Derivative Assay, Immunofluorescence, Hot Plate Test, Control

    Conditional knockout of TGF-β type 2 receptor ( Tgfbr2 ) in pericytes reduces fibrotic scar formation in SCI mice. a Schematic diagram of Tgfbr2 knockout in Glast-Cre + pericytes. b Representative images of immunofluorescent analysis of PGP9.5 + (red) nerve fibers, fibronectin + (green) fibrotic scar, and DAPI (blue) staining of nuclei at 4 weeks after SCI. Scale bar, 200 µm. c , d Quantitative analysis of the intensity value of PGP9.5 and fibronectin (* P < 0.05, n = 6). e Representative images of immunofluorescent analysis of nerve axon–specific β-III-tubulin + (green), collagen III + (red) fibrotic scar, and DAPI (blue) staining of nuclei at 4 weeks after SCI. Scale bar, 200 µm. Right images are high resolution versions of the boxed regions in the left images. Scale bar, 50 µm. f Quantitative analysis of the intensity value of collagen III (* P < 0.05, n = 6). g Representative images of immunofluorescent analysis of neurotransmitter marker 5-HT + (red), nerve axon–specific β-III-tubulin + (green), and DAPI (blue) staining of nuclei in spinal cord lesion site of T10 in Tgfbr2 flox/flox sham group mice, Tgfbr2 flox/flox control mice, and Tgfbr2 Glast-creER −/− mice at 4 weeks after SCI. Scale bar, 200 µm. Right images are high-resolution versions of the boxed regions in the left images. Scale bar, 50 µm. h , i Quantitative analysis of the intensity value of 5-HT and β-III-tubulin (* P < 0.05, n = 6). j Representative images of immunofluorescent analysis of pSmad2 + (red), PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. k , l Quantitative analysis of the intensity mean value of PDGFR-β and the number of pSmad2 + cells (*** P < 0.001, **** P < 0.000 1, n = 6). m Representative Western blots showing the activation of pSmad signaling. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Journal: Bone Research

    Article Title: TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury

    doi: 10.1038/s41413-026-00507-7

    Figure Lengend Snippet: Conditional knockout of TGF-β type 2 receptor ( Tgfbr2 ) in pericytes reduces fibrotic scar formation in SCI mice. a Schematic diagram of Tgfbr2 knockout in Glast-Cre + pericytes. b Representative images of immunofluorescent analysis of PGP9.5 + (red) nerve fibers, fibronectin + (green) fibrotic scar, and DAPI (blue) staining of nuclei at 4 weeks after SCI. Scale bar, 200 µm. c , d Quantitative analysis of the intensity value of PGP9.5 and fibronectin (* P < 0.05, n = 6). e Representative images of immunofluorescent analysis of nerve axon–specific β-III-tubulin + (green), collagen III + (red) fibrotic scar, and DAPI (blue) staining of nuclei at 4 weeks after SCI. Scale bar, 200 µm. Right images are high resolution versions of the boxed regions in the left images. Scale bar, 50 µm. f Quantitative analysis of the intensity value of collagen III (* P < 0.05, n = 6). g Representative images of immunofluorescent analysis of neurotransmitter marker 5-HT + (red), nerve axon–specific β-III-tubulin + (green), and DAPI (blue) staining of nuclei in spinal cord lesion site of T10 in Tgfbr2 flox/flox sham group mice, Tgfbr2 flox/flox control mice, and Tgfbr2 Glast-creER −/− mice at 4 weeks after SCI. Scale bar, 200 µm. Right images are high-resolution versions of the boxed regions in the left images. Scale bar, 50 µm. h , i Quantitative analysis of the intensity value of 5-HT and β-III-tubulin (* P < 0.05, n = 6). j Representative images of immunofluorescent analysis of pSmad2 + (red), PDGFR-β + (green) pericytes and DAPI (blue) staining of nuclei at 7 days after SCI. Scale bar, 10 µm. k , l Quantitative analysis of the intensity mean value of PDGFR-β and the number of pSmad2 + cells (*** P < 0.001, **** P < 0.000 1, n = 6). m Representative Western blots showing the activation of pSmad signaling. Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Article Snippet: The sections were incubated with primary antibodies to rabbit 5-HT (1:50, sc-65495, Santa Cruz Biotechnology, Dallas, TX, USA), mouse β-III-tubulin (1:100, MA1-118, Invitrogen, Carlsbad, CA, USA), rabbit PGP9.5 (1:250, ab108986, Abcam, Cambridge, UK), mouse PGP9.5 (1:50, ab8189, Abcam), rabbit Fibronectin (1:100, ab2413, Abcam), mouse Fibronectin (1:100, ab6328, Abcam), rabbit Collagen III (1:100, ab7778, Abcam), chicken GFAP (1:500, ab4674, Abcam), mouse Collagen1α1 (1:50, sc-293182, Santa Cruz Biotechnology), rabbit Phospho SAMD2 (1:100, 44-244 G, Invitrogen), rabbit PDGFR-β (1:100, ab32570, Abcam), goat PDGFR-β (1:100, AF1042, R&D Systems), rabbit FSP1 (1:300, 07-2274, MilliporeSigma, Burlington, MA, USA), and chicken green fluorescent protein (1:250, ab13970, Abcam) overnight at 4 °C.

    Techniques: Knock-Out, Staining, Marker, Control, Western Blot, Activation Assay

    LepR + MSCs are the primary cells for fibrotic scar formation. a , b Diagram illustrating the genetic strategy to trace type A pericytes and the timeline of tamoxifen injection. c Representative images of immunofluorescent analysis of tdT + (red) type A pericytes, PDGFR-β + (green) pericytes, and DAPI (blue) staining of nuclei in the spinal cord lesion site of T10 wild-type (WT) mice at 2 weeks after SCI. Scale bar, 50 µm. Left images are high-resolution versions of the boxed regions in the right images. Scale bar, 10 µm. d Quantitative analysis of percentage of PDGFR-β cells/tdTomato + type A pericytes cells (*** P < 0.001, n = 4). e Representative images of immunofluorescent analysis of collagen III + (Col-III green) fibrotic scar, tdT + (red) type A pericytes, and DAPI (blue) staining of nuclei in spinal cord lesion site of T10 in 13C4 group control mice and 1D11 group mice at 4 weeks after SCI. Scale bar, 50 µm. f Quantitative analysis of percentage of collagen III + area /tdTomato + type A pericytes field (*** P < 0.001, n = 4). g Representative images of immunofluorescent analysis of LepR + (green) MSCs, tdT + (red) type A pericytes, and DAPI (blue) staining of nuclei in sham group mice, 13C4 group control mice, and 1D11 group mice at 4 weeks after SCI. Scale bar, 50 µm. h Quantitative analysis of the percentage of LepR + cells/tdTomato + cells (* P < 0.05, n = 4). i Representative images of immunofluorescent analysis of LepR + (green) MSCs, collagen III + (Col-III, green) fibrotic scar , and DAPI (blue) staining of nuclei. Scale bar, 50 µm. j Quantitative analysis of the percentage of collagen III + area/ LepR + MSCs field (** P < 0.01, n = 4). k Representative images of immunofluorescent analysis of LepR + (green) MSCs, FSP1 + (red) type A pericytes , and DAPI (blue) staining of nuclei. Scale bar, 50 µm. l Quantitative analysis of the percentage of LepR + MSCs/FSP1 + cells (** P < 0.01, n = 4). Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Journal: Bone Research

    Article Title: TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury

    doi: 10.1038/s41413-026-00507-7

    Figure Lengend Snippet: LepR + MSCs are the primary cells for fibrotic scar formation. a , b Diagram illustrating the genetic strategy to trace type A pericytes and the timeline of tamoxifen injection. c Representative images of immunofluorescent analysis of tdT + (red) type A pericytes, PDGFR-β + (green) pericytes, and DAPI (blue) staining of nuclei in the spinal cord lesion site of T10 wild-type (WT) mice at 2 weeks after SCI. Scale bar, 50 µm. Left images are high-resolution versions of the boxed regions in the right images. Scale bar, 10 µm. d Quantitative analysis of percentage of PDGFR-β cells/tdTomato + type A pericytes cells (*** P < 0.001, n = 4). e Representative images of immunofluorescent analysis of collagen III + (Col-III green) fibrotic scar, tdT + (red) type A pericytes, and DAPI (blue) staining of nuclei in spinal cord lesion site of T10 in 13C4 group control mice and 1D11 group mice at 4 weeks after SCI. Scale bar, 50 µm. f Quantitative analysis of percentage of collagen III + area /tdTomato + type A pericytes field (*** P < 0.001, n = 4). g Representative images of immunofluorescent analysis of LepR + (green) MSCs, tdT + (red) type A pericytes, and DAPI (blue) staining of nuclei in sham group mice, 13C4 group control mice, and 1D11 group mice at 4 weeks after SCI. Scale bar, 50 µm. h Quantitative analysis of the percentage of LepR + cells/tdTomato + cells (* P < 0.05, n = 4). i Representative images of immunofluorescent analysis of LepR + (green) MSCs, collagen III + (Col-III, green) fibrotic scar , and DAPI (blue) staining of nuclei. Scale bar, 50 µm. j Quantitative analysis of the percentage of collagen III + area/ LepR + MSCs field (** P < 0.01, n = 4). k Representative images of immunofluorescent analysis of LepR + (green) MSCs, FSP1 + (red) type A pericytes , and DAPI (blue) staining of nuclei. Scale bar, 50 µm. l Quantitative analysis of the percentage of LepR + MSCs/FSP1 + cells (** P < 0.01, n = 4). Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Article Snippet: The sections were incubated with primary antibodies to rabbit 5-HT (1:50, sc-65495, Santa Cruz Biotechnology, Dallas, TX, USA), mouse β-III-tubulin (1:100, MA1-118, Invitrogen, Carlsbad, CA, USA), rabbit PGP9.5 (1:250, ab108986, Abcam, Cambridge, UK), mouse PGP9.5 (1:50, ab8189, Abcam), rabbit Fibronectin (1:100, ab2413, Abcam), mouse Fibronectin (1:100, ab6328, Abcam), rabbit Collagen III (1:100, ab7778, Abcam), chicken GFAP (1:500, ab4674, Abcam), mouse Collagen1α1 (1:50, sc-293182, Santa Cruz Biotechnology), rabbit Phospho SAMD2 (1:100, 44-244 G, Invitrogen), rabbit PDGFR-β (1:100, ab32570, Abcam), goat PDGFR-β (1:100, AF1042, R&D Systems), rabbit FSP1 (1:300, 07-2274, MilliporeSigma, Burlington, MA, USA), and chicken green fluorescent protein (1:250, ab13970, Abcam) overnight at 4 °C.

    Techniques: Injection, Staining, Control

    Neonatal mice completely recover from SCI without scarring. a Schematic diagram illustrating the timeline of the experimental procedures. b Representative images of immunofluorescent analysis of pSmad2 (red), PDGFR-β (green), and DAPI (blue) in the spinal cord lesion site in neonatal mice on days 2, 7, and 12 with or without SCI. Scale bar, 50 µm. Right images are high-resolution versions of the boxed regions in the left images. Scale bar, 50 µm. c , d Quantitative analysis of the number of pSmad2 + cells and PDGFR-β + cells (** P < 0.01, *** P < 0.001, **** P < 0.000 1, n = 6). e Representative images of immunofluorescent analysis of β-III-tubulin (green), collagen III (red), and DAPI (blue) in the spinal cord lesion site in neonatal mice on days 2 and 12, and adult mice with or without SCI. Scale bar, 200 µm. f , g Quantitative analysis of the intensity mean value of collagen III + fibrotic scar and β-III-tubulin + nerves (* P < 0.05, **** P < 0.000 1, n = 6). Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Journal: Bone Research

    Article Title: TGF-β-induced fibrotic scar formation limits recovery of spinal cord injury

    doi: 10.1038/s41413-026-00507-7

    Figure Lengend Snippet: Neonatal mice completely recover from SCI without scarring. a Schematic diagram illustrating the timeline of the experimental procedures. b Representative images of immunofluorescent analysis of pSmad2 (red), PDGFR-β (green), and DAPI (blue) in the spinal cord lesion site in neonatal mice on days 2, 7, and 12 with or without SCI. Scale bar, 50 µm. Right images are high-resolution versions of the boxed regions in the left images. Scale bar, 50 µm. c , d Quantitative analysis of the number of pSmad2 + cells and PDGFR-β + cells (** P < 0.01, *** P < 0.001, **** P < 0.000 1, n = 6). e Representative images of immunofluorescent analysis of β-III-tubulin (green), collagen III (red), and DAPI (blue) in the spinal cord lesion site in neonatal mice on days 2 and 12, and adult mice with or without SCI. Scale bar, 200 µm. f , g Quantitative analysis of the intensity mean value of collagen III + fibrotic scar and β-III-tubulin + nerves (* P < 0.05, **** P < 0.000 1, n = 6). Statistical significance was determined by multifactorial ANOVA, and all data are shown as means ± standard deviations. Source data are provided as a Source Data file

    Article Snippet: The sections were incubated with primary antibodies to rabbit 5-HT (1:50, sc-65495, Santa Cruz Biotechnology, Dallas, TX, USA), mouse β-III-tubulin (1:100, MA1-118, Invitrogen, Carlsbad, CA, USA), rabbit PGP9.5 (1:250, ab108986, Abcam, Cambridge, UK), mouse PGP9.5 (1:50, ab8189, Abcam), rabbit Fibronectin (1:100, ab2413, Abcam), mouse Fibronectin (1:100, ab6328, Abcam), rabbit Collagen III (1:100, ab7778, Abcam), chicken GFAP (1:500, ab4674, Abcam), mouse Collagen1α1 (1:50, sc-293182, Santa Cruz Biotechnology), rabbit Phospho SAMD2 (1:100, 44-244 G, Invitrogen), rabbit PDGFR-β (1:100, ab32570, Abcam), goat PDGFR-β (1:100, AF1042, R&D Systems), rabbit FSP1 (1:300, 07-2274, MilliporeSigma, Burlington, MA, USA), and chicken green fluorescent protein (1:250, ab13970, Abcam) overnight at 4 °C.

    Techniques: